Invention Grant
- Patent Title: Substituted indazole derivatives as in vitro MAO-B inhibitors
-
Application No.: US14760441Application Date: 2013-06-05
-
Publication No.: US09643930B2Publication Date: 2017-05-09
- Inventor: Nikolay Tzvetkov
- Applicant: “NTZ LAB” LTD.
- Applicant Address: BG Sofia
- Assignee: “NTZ LAB” LTD.
- Current Assignee: “NTZ LAB” LTD.
- Current Assignee Address: BG Sofia
- Agency: Baker Hostetler LLP
- Priority: BG111378 20130114
- International Application: PCT/BG2013/000025 WO 20130605
- International Announcement: WO2014/107771 WO 20140717
- Main IPC: C07D231/56
- IPC: C07D231/56 ; C07D401/12 ; A61K31/4045 ; A61K31/416
Abstract:
Substituted indazole or imidazole derivatives of formula I as an in vitro selective and reversible MAO-B inhibitors and for use in the prevention and treatment of neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease and dementia.
Public/Granted literature
- US20150353504A1 SUBSTITUTED INDAZOLE DERIVATIVES AS IN VITRO MAO-B INHIBITORS Public/Granted day:2015-12-10
Information query
